A randomized trial comparing 4.8 vs. 2.4 g/day of oral mesalazine for maintenance of remission in ulcerative colitis

Autor: Pica, Roberta, Cassieri, Claudio, Cocco, Andrea, Zippi, Maddalena, Marcheggiano, Adriana, De Nitto, Daniela, Avallone, Eleonora Veronica, Crispino, Pietro, Occhigrossi, Giuseppe, Paoluzi, Paolo
Zdroj: In Digestive and Liver Disease November 2015 47(11):933-937
Databáze: ScienceDirect